Keyphrases
African American
16%
Age 50
16%
City Population
16%
Colonoscopy
50%
Colorectal Cancer Screening
33%
Cost Savings
16%
Cost-effectiveness
100%
Fecal Immunochemical Test
66%
Fecal Occult Blood Test
33%
Healthcare Models
16%
Hispanic
16%
Individual Age
16%
Life-years Gained
66%
Minority Patients
16%
Minority Populations
16%
Model Validation
16%
Navigation Cost
83%
New York City
16%
Participation Rate
16%
Patient Navigation
100%
Payers
33%
Population Health
16%
Probabilistic Sensitivity Analysis
16%
Quality-adjusted Life Years
83%
Reward Outcome
16%
Screening Colonoscopy
100%
Screening Participation
16%
Screening Uptake
16%
Testing Uptake
16%
Uptake Rate
16%
Medicine and Dentistry
Base
18%
Colonoscopy
100%
Colorectal Cancer Screening
18%
Cost-Effectiveness Analysis
100%
Health Care
9%
Health Care Cost
100%
Malignant Neoplasm
9%
Patient Care
100%
Population Health
9%
Quality Adjusted Life Year
45%
Uptake Rates
9%
Urban Population
9%
Nursing and Health Professions
Base
22%
Cancer Screening
22%
Colonoscopy
100%
Colorectal Carcinoma
22%
Cost Control
11%
Cost Effectiveness Analysis
100%
Health Service
11%
Malignant Neoplasm
11%
Occult Blood
22%
Patient Care
100%
Quality Adjusted Life Year
55%
Urban Population
11%
Biochemistry, Genetics and Molecular Biology
Cancer Screening
40%
Fecal Occult Blood
40%
Population Health
20%
Quality Adjusted Life Year
100%
Urban Population
20%